The Advanced Visualizer

ConcertAI's TeraRecon, Integrates Clinical and Generative AI, Supporting Clinical Research and Advancing Clinical Care Solutions at #RSNA23

Retrieved on: 
Monday, November 20, 2023
Dark, CT scan, RSNA, Generative, Gen, Research, Real, Catalog, Pneumothorax, Human, The Advanced Visualizer, Synthetic media, Collection, Cardiology, Physician, PACS, Scientist, Hospital, Patient, Education minister, Data analysis, Multi, Algorithm, Lurie Children's Hospital, Q&A, Trial of the century, Diagnosis, Doctor of Philosophy, Health care, AI, MSKCC, Health, Medical imaging, Medical device, Nightclub

CAMBRIDGE, Mass., Nov. 20, 2023 /PRNewswire/ -- ConcertAI's TeraRecon, the advanced visualization and clinical AI leader, recently unveiled first-in-category capabilities in advanced visualization, AI, and expansions to its AI partner ecosystem to enhance research capabilities and support complex clinical study workflows. These solutions will provide researchers with enhanced data analysis tools for in-depth study, contributing to more informed care strategies that can improve patient outcomes.

Key Points: 
  • New solutions empower clinicians and research teams with AI orchestration, model development, visualization, and multi-modal data management to power clinical research, clinical trials, and patient care strategies.
  • These solutions will provide researchers with enhanced data analysis tools for in-depth study, contributing to more informed care strategies that can improve patient outcomes.
  • Leveraging ConcertAI's Eureka Life Science AI Platform, powered by TeraRecon, MSKCC will drive advancements in multi-modal AI workflows, using clinical and radiological imaging data.
  • Our joint vision is clear: advance the utility and efficacy of Clinical AI in oncology research, extending its benefits to more patients and institutions in the future.

PR Newswire Exhibitor Profiles: RSNA 2023

Retrieved on: 
Monday, November 20, 2023
Calibration, Health, RSNA, Peter Wells (athlete), SDK, The Advanced Visualizer, Physician Quality Reporting System, DBI, Artificial intelligence, PACS, History, Radiology, Tornwaldt cyst, Algorithm, Heart, Ubuntu-Med, Visage SDK, Workflow, Booth, OEM, Software, Diagnosis, Illuminate, MRI, AI, Physician, Architecture, Customer service, Medical imaging

NEW YORK, Nov. 20, 2023 /PRNewswire/ -- The following event roundup from PR Newswire is a list of featured exhibitors for RSNA 2023, the must-attend conference for radiology professionals, which takes place from November 26 – 30 at at McCormick Place in Chicago, Illinois.

Key Points: 
  • Double Black Imaging is dedicated to developing innovative imaging solutions that greatly improve image quality and stability.
  • Fovia, Inc. is a world leader in advanced visualization, a preeminent provider of cloud-based, zero-footprint imaging SDKs, to OEM partners.
  • As the developer of High Definition Volume Rendering® Fovia's software enables advanced diagnostic applications, custom workflows and high-performance interactive imaging.
  • Visit Fovia Ai at Booth 4161 at RSNA to learn more, or visit fovia.ai and fovia.com.

Addressing radiology workload challenges: Sectra and GE HealthCare plan to leverage deep integration to help enhance clinical efficiency

Retrieved on: 
Thursday, November 9, 2023
Suite, Annual general meeting, Cardiology, The Advanced Visualizer, Deep learning, International, GE HealthCare, Aw family, Workflow, Automation, Radiology, API, AI, Workload, Face, Medical imaging, Sectra AB, Imaging

The integration will be made possible with Sectra's open API and GE HealthCare's open ecosystem.

Key Points: 
  • The integration will be made possible with Sectra's open API and GE HealthCare's open ecosystem.
  • When combined with Sectra's diagnostic application, clinicians could enhance CardIQ Suite's efficiency, potentially enabling faster workflows, additional time savings, increased productivity, and a reduced workload.
  • The AI-enabled application is intended to help with consistency, accurate labeling, and correct identification of the presence of coronary artery classifications.
  • For more information on this integration, visit the booths of Sectra (#8113) and GE HealthCare (#7326) at the Radiological Society of North America 2023 Annual Meeting.

ConcertAI's TeraRecon Showcases New Clinical and AI Solutions Designed to Enhance Treatment Planning for Structural Heart Patients at TCT 2023

Retrieved on: 
Monday, October 23, 2023
Digital twin, Digital, FDA, The Advanced Visualizer, Physician, FACC, CE, Cardiology, PM, Intuition, TMVR, AV, Artificial intelligence, Radiology, LAA, Partnership, Neurology, Workflow, FHRS, TCT, Patient, CT scan, Medical imaging, Medical device, MD

NEW strategic partnership to offer FEops HEARTguide™ Digital Twin solution for an elevated structural heart experience for LAA closure procedures.

Key Points: 
  • NEW strategic partnership to offer FEops HEARTguide™ Digital Twin solution for an elevated structural heart experience for LAA closure procedures.
  • LIVE physician-led presentations on advancing cardiac care utilizing Intuition 4.7, and FEops solutions.
  • Cardiology Suite applications on the Eureka Clinical AI platform are FDA and CE-cleared with additional regional clearances.
  • FEops HEARTguide is a unique cloud-based procedure planning solution in the structural heart, based on Digital Twin technologies.

Thermo Fisher Scientific Announces the Launch of the EXENT® Solution with IVDR Certification

Retrieved on: 
Thursday, August 24, 2023
Research, Technology, Professional Services, Software, Biotechnology, Data Analytics, Health, Data Management, Science, Oncology, Mayo Clinic, IVDR, Serum, Multiple myeloma, Immunoglobulin M, Bone marrow, Immunoassay, GAM, Thermo Fisher Scientific, Immunoglobulin A, Binding site, The Advanced Visualizer, HIV disease progression rates, Acquisition, Patient, Laboratory, Immunoglobulin G, Diagnosis, Matrix-assisted laser desorption/ionization, World Health Organization, Medical device, Medical imaging, Fine chemical

Thermo Fisher Scientific, the world leader in serving science, today announced the commercial launch of the EXENT® Solution, after receiving IVDR certification*.

Key Points: 
  • Thermo Fisher Scientific, the world leader in serving science, today announced the commercial launch of the EXENT® Solution, after receiving IVDR certification*.
  • The EXENT Solution is now commercially available in the following countries: Belgium, France, Germany, Italy, the Netherlands, Spain and United Kingdom.
  • “The EXENT Solution represents a significant breakthrough in innovation for the detection and monitoring of monoclonal immunoglobulins,” said Dr. Stephen Harding, Chief Scientific Officer, Protein Diagnostics, Thermo Fisher.
  • Earlier this year, Thermo Fisher Scientific completed the acquisition of The Binding Site, adding protein diagnostics solutions, including diagnosis and monitoring for monoclonal gammopathies, to its specialty diagnostics portfolio.

Bracken Welcomes New Consultants Deepak Behera, MD, and Gitte Andreasen, Providing Expertise in Radiopharmaceuticals and Marketing, Respectively

Retrieved on: 
Wednesday, February 8, 2023
Proton, Professional, Fraction, Mammography, Diagnosis, MRI, Partnership, Philips, Nuclear medicine, The Advanced Visualizer, Proton therapy, Gitte Moos Knudsen, Abdominal ultrasonography, Marketing, GE HealthCare, IBA, Radiopharmaceutical, Pharmaceutical industry, Medical imaging

With the addition of these experts in their respective fields, the consulting group continues to leverage wisdom and collective expertise—advancing Bracken's intelligence ecosystem.

Key Points: 
  • With the addition of these experts in their respective fields, the consulting group continues to leverage wisdom and collective expertise—advancing Bracken's intelligence ecosystem.
  • Deepak is a highly accomplished nuclear medicine trained physician-scientist and executive with over 20 years of experience in nuclear medicine, specifically in clinical development, medical affairs, product launches, and radiopharmaceuticals.
  • He has an extensive background in the clinical, academic, and pharmaceutical/biotech sectors, has published more than 20 journal articles, and co-authored 2 patents.
  • Deepak's background as a nuclear medicine physician-scientist and industry executive offers exceptional deftness to his consulting work within the pharma/biotech/radiopharmaceutical industry.

INFINITT announces collaboration with Hamamatsu, a leading manufacturer of whole slide scanners

Retrieved on: 
Tuesday, September 20, 2022
PACS, Workflow, Adoption, LIS, RIS, Laboratory, Marie Cassidy, Algorithm, Risk, IDPS, Organization, Review, INFINITT Healthcare, VNA, CEO, MDT, Digital pathology, The Advanced Visualizer, Solution, Pathology, EMR, Hamamatsu Photonics, Ophthalmology, RT, AI, Communication, Television, Medical imaging

PHILLIPSBURG, N.J., Sept. 20, 2022 /PRNewswire-PRWeb/ -- By partnering with Hamamatsu, INFINITT can offer an enhanced integration with NanoZoomers, enabling laboratories and pathologists to seamlessly review slides in an end-to-end operational workflow. Further, the ability of IDPS to integrate with LIS will allow pathologists to work more efficiently in a digital environment.

Key Points: 
  • INFINITT North America, an award-winning developer of enterprise imaging solutions for healthcare, announced a collaboration with Hamamatsu Corporation to jointly promote Hamamatsu whole slide scanners (NanoZoomers*) and INFINITT Digital Pathology Solution (IDPS) to its United States customers.
  • Further, the ability of IDPS to integrate with LIS will allow pathologists to work more efficiently in a digital environment.
  • Hamamatsu's NanoZoomer series of whole slide scanners have been developed with almost 70 years of experience in photonics.
  • Hamamatsu and INFINITT bring together Hamamatsu's NanoZoomer whole slide scanners with INFINITT's enterprise platform to manage images, data, and algorithms to streamline pathology workflows.

INFINITT announces collaboration with Hamamatsu, a leading manufacturer of whole slide scanners

Retrieved on: 
Tuesday, September 20, 2022
PACS, Workflow, Adoption, LIS, RIS, Laboratory, Marie Cassidy, Algorithm, Risk, IDPS, Hamamatsu, Organization, Health, Review, INFINITT Healthcare, VNA, CEO, MDT, Digital pathology, The Advanced Visualizer, Solution, Pathology, EMR, Hamamatsu Photonics, Ophthalmology, RT, Multimedia, AI, Communication, Television, Medical imaging

By partnering with Hamamatsu, INFINITT can offer an enhanced integration with NanoZoomers, enabling laboratories and pathologists to seamlessly review slides in an end-to-end operational workflow.

Key Points: 
  • By partnering with Hamamatsu, INFINITT can offer an enhanced integration with NanoZoomers, enabling laboratories and pathologists to seamlessly review slides in an end-to-end operational workflow.
  • Further, the ability of IDPS to integrate with LIS will allow pathologists to work more efficiently in a digital environment.
  • As laboratories adopt digital pathology, they must leverage a complex hardware and software solutions ecosystem to facilitate pathologists' workflow.
  • Hamamatsu and INFINITT bring together Hamamatsu's NanoZoomer whole slide scanners with INFINITT's enterprise platform to manage images, data, and algorithms to streamline pathology workflows.

Brainomix Expands Leadership Team with Appointment of Melissa Strange as Chief Financial Officer and Jérôme Galbrun as Chief Revenue Officer

Retrieved on: 
Tuesday, July 19, 2022
Stroke, University, Master, Tokyo Institute of Technology, Cancer, Patient, LinkedIn, Solution, HR, Hospital, Neurology, Health, Tencent, Melissa, University of Law, Medtech, LLB, Twitter, AI, Adoption, Pulmonary fibrosis, Marketing, Postgraduate diploma, Business development, Electronic health record, Agfa-Gevaert, Master of Management: Co-operatives and Credit Unions, The Advanced Visualizer, GE Healthcare, Michael Smurfit Graduate Business School, Physician, Industry, Precision medicine, CRO, Company, OXFORD, Cardiology, Growth, Senior, Hewlett-Packard, Oxford Brookes University, Doctor of Philosophy, Biomarker, Therapy, CFO, KLAS, Clinical trial, University of Oxford, EMR, Management, Medical device, Pharmaceutical industry, Facebook

The expansion in the leadership team reflects the Company's growth and maturity since closing its 16M ($21.2M) series B financing in December 2021.

Key Points: 
  • The expansion in the leadership team reflects the Company's growth and maturity since closing its 16M ($21.2M) series B financing in December 2021.
  • The team has more than doubled since the start of the year, with additional hiring planned for the remainder of 2022.
  • Melissa will lead finance, HR and operations, bringing extensive experience to help guide the Company's future direction.
  • Melissa joins from Closed Loop Medicine where she led on finance and strategy as CFO, including closure of a 13m Series A financing.

INFINITT North America Announces Collaboration with Brainreader A/S to Market Neuro AI for Brain Structure Analysis

Retrieved on: 
Thursday, June 9, 2022
Digital pathology, Science, Ophthalmology, Atrophy, AI, Magnetic resonance imaging, CEO, Partnership, RIS, Solution, FDA, PACS, VNA, Diagnosis, INFINITT Healthcare, The Advanced Visualizer, RT, MRI, Medical imaging

PHILLIPSBURG, N.J., June 9, 2022 /PRNewswire-PRWeb/ -- INFINITT North America and Brainreader A/S announced today a wide ranging and unique partnership to expand and deepen the use of Brainreader's FDA cleared Neuroreader software. Neuroreader Report analyzes an MRI sequence to determine whether brain structures are abnormal and to what extent. It visualizes and quantifies 45 individual brain structures in less than ten minutes after Magnetic Resonance Imaging.

Key Points: 
  • INFINITT North America and Brainreader A/S announced today a wide ranging and unique partnership to expand and deepen the use of Brainreader's FDA cleared Neuroreader software.
  • It visualizes and quantifies 45 individual brain structures in less than ten minutes after Magnetic Resonance Imaging.
  • PHILLIPSBURG, N.J., June 9, 2022 /PRNewswire-PRWeb/ -- INFINITT North America and Brainreader A/S announced today a wide ranging and unique partnership to expand and deepen the use of Brainreader's FDA cleared Neuroreader software.
  • INFINITT North America is the North American business unit of INFINITT Healthcare, a global company with more than 6500 installations in 55 countries.